Scientists Use Light to Unlock New Bacterial Superpowers

Scientists just taught ordinary bacteria an extraordinary new trick that could transform how we make everything from life-saving drugs to agricultural chemicals.

A research team at the University of Illinois engineered E. coli bacteria to produce completely new types of molecules by activating special enzymes with light. Without the light, nothing happens. Shine a light on these modified microbes, and they suddenly gain superpowers nature never gave them.

The breakthrough addresses a major limitation in biomanufacturing. While using microorganisms to produce medicines and chemicals is more sustainable than traditional manufacturing, enzymes can only catalyze a limited number of chemical reactions. That means there are countless useful molecules we simply can't make using biological processes.

Professor Huimin Zhao and his team solved this by creating artificial photoenzymes that combine light activation with enzymatic reactions. These hybrid enzymes can perform chemical transformations that natural enzymes can't achieve and that are extremely difficult or impossible with conventional chemistry alone.

The real innovation came when postdoctoral researcher Yujie Yuan figured out how to make this work inside living cells. Previous attempts only succeeded in test tubes. Yuan's team engineered the bacteria to produce everything needed for these light-driven reactions internally, including special molecules called free radicals. No external ingredients required.

The researchers tested their platform with six different photoenzymatic reactions and successfully scaled up four of them in bioreactors. The bacteria converted cheap glucose into higher-value products, all powered by light.

Why This Inspires

This discovery opens doors to sustainable production of medicines and materials we've struggled to create efficiently. Instead of energy-intensive chemical factories, imagine warehouses of bacteria in light-filled bioreactors, quietly converting simple sugars into complex pharmaceuticals.

The implications extend beyond any single product. This platform technology could enable an entirely new generation of biomanufacturing processes, making production cheaper, cleaner, and more accessible.

There's still work ahead. The amounts of product produced need improvement for commercial viability, and specialized bioreactors designed for light-driven processes don't yet exist. But companies are already interested in developing custom equipment.

The team's next goal is synthesizing FDA-approved drugs and herbicides using this approach. They've proven the concept works, and now they're scaling up to change how we make the molecules modern life depends on.

Sometimes the brightest solutions really do require a little light.